- SEK53.81bn
- SEK60.84bn
- SEK34.97bn
Brief: Getinge - Launch Of Vasoview Hemopro 3 To Occur In US During Q3 2024
Brief: - FDA Grants Clearance For Getinge's Vasoview Hemopro 3
Brief: Tüv Süd Temporarily Suspends Getinge's CE Certificate For Cardiosave
Europe Research Roundup: Adidas, Fevertree Drinks, Volvo Car
Getinge shares plummet on Q4 profit miss
Brief: Getinge Proposes Dividend Of SEK 4.4 Per Share
Medical gear maker Getinge's Q4 operating profit lags expectations (updated)
Medical gear maker Getinge's Q4 operating profit lags expectations
Brief: Getinge Q4 Adjusted EBITA SEK 1,318 Million
Earnings Poll: Getinge AB fourth quarter results due on February 1
Ericsson appoints Lars Sandstrom as new CFO (updated)
Brief: Agneta Palmér Appointed New CFO Of Getinge
Europe Research Roundup: Epiroc AB, Inficon Holding AG, VAT Group AG
Brief: FDA Says Getinge Recalls Cardiohelp Emergency Drive Due To An Impaired Or Inability To Turn The Drive
Europe Research Roundup: Duerr, Sika AG, Tomra Systems ASA
Brief: Getinge CEO: Will Need To See Momentum Change To Be More Comfortable With 4-6% Organic Growth In Net Sales
Getinge rises on Q3 beat
Brief: Getinge Keeps 2023 Outlook Unchanged
Medical gear maker Getinge's Q3 core profit drops on weak demand, high costs (updated)